Placebo matching to dupilumab, Dupixent 300 mg solution for injection in pre-filled syringe clinical trials

A phase IV, randomized double blinded placebo-controlled study on the barrier restoring capacity of Dupilumab in type 2 airway disease: CRSwNP

This study is looking at how a medicine called Dupixent (Dupilumab) might help people with long-term stuffy nose and growths called nasal polyps. We want to see if it helps fix the natural barrier in the nose lining.